INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 63 filers reported holding INSTIL BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17,096 | -2.3% | 25,872 | -6.9% | 0.00% | – |
| Q4 2022 | $17,501 | -86.8% | 27,780 | +1.1% | 0.00% | – |
| Q3 2022 | $133,000 | -2.9% | 27,467 | -7.7% | 0.00% | – |
| Q2 2022 | $137,000 | -45.2% | 29,757 | +28.2% | 0.00% | – |
| Q1 2022 | $250,000 | -50.4% | 23,218 | -21.2% | 0.00% | -100.0% |
| Q4 2021 | $504,000 | +200.0% | 29,457 | +213.8% | 0.00% | – |
| Q3 2021 | $168,000 | -63.9% | 9,386 | -61.0% | 0.00% | -100.0% |
| Q2 2021 | $465,000 | – | 24,054 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $408,285,000 | 100.00% |
| CPMG Inc | 8,218,467 | $88,349,000 | 14.82% |
| VR Adviser, LLC | 6,865,076 | $73,800,000 | 11.96% |
| Vivo Capital, LLC | 12,486,787 | $134,233,000 | 9.24% |
| Samsara BioCapital, LLC | 1,991,950 | $21,413,000 | 5.39% |
| Fairmount Funds Management LLC | 673,905 | $7,244,000 | 1.71% |
| RA Capital Management | 4,870,793 | $52,361,000 | 1.14% |
| Nicholas Investment Partners, LP | 762,388 | $8,196,000 | 0.58% |
| HHLR ADVISORS, LTD. | 2,385,457 | $25,644,000 | 0.54% |
| Logos Global Management LP | 377,091 | $4,054,000 | 0.53% |